Blog
RSS FeedPosted by Michael Wonder on 08 Jun 2020
Health economic assessment of Polivy in combination with bendamustine and rituximab
5 June 2020 - The treatment is intended for adult patients with diffuse large-cell B-cell lymphomas who relapse or do not ...
Posted by Michael Wonder on 02 Jun 2020
More patients have access to medicines within the high-cost protection system
2 June 2020 - From today, patients who pick up prescription drugs at pharmacies will be able to switch to ...
Posted by Michael Wonder on 01 Jun 2020
Health economic assessment of Vimizim in mucopolysaccharidosis type IVA (Morquio A syndrome)
29 May 2020 - TLV has developed a health economic knowledge base for the regions of the drug Vimizim (elosulfase alfa) ...
Posted by Michael Wonder on 28 May 2020
TLV has decided to reconsider the subsidy status for certain drugs
26 May 2020 - TLV initiates a review for review of subsidy status for drugs that are part of one ...
Posted by Michael Wonder on 18 May 2020
Health economic assessment of Bavencio and Inlyta
18 May 2020 - TLV has developed a health economic assessment for the regions regarding the combination of avelumab (Bavencio) and ...
Posted by Michael Wonder on 14 May 2020
Camurus' Buvidal reimbursed in Sweden for the treatment of opioid dependence
14 May 2020 - Buvidal (buprenorphine) prolonged release injection receives reimbursement in Sweden from the 15 May 2020 after approval by ...
Posted by Michael Wonder on 14 May 2020
Health economic assessment of Spravato in treatment resistant depression
14 May 2020 - TLV has developed a health economic knowledge base for the regions for Spravato (esketamine). ...
Posted by Michael Wonder on 12 May 2020
Third evaluation within the FINOSE collaboration
12 May 2020 - Together with the corresponding authorities in Finland and Norway, TLV has produced a joint evaluation report ...
Posted by Michael Wonder on 11 May 2020
Health economic assessment of gene therapy Zynteglo in transfusion-dependent beta-thalassemia
11 May 2020 - TLV has developed a health-economic knowledge base for the Zynteglo gene therapy (autologous CD34-positive cells expressing the ...
Posted by Michael Wonder on 08 May 2020
HyQvia gets a higher price
8 May 2020 - HyQvia 100 mg/mL solution for injection contains human immunoglobulin, which is an antibody used to strengthen ...
Posted by Michael Wonder on 30 Apr 2020
Health economic assessment of Keytruda in head and neck cancer
29 April 2020 - TLV has developed a health economic knowledge base for the regions of the drug Keytruda (pembrolizumab). ...
Posted by Michael Wonder on 20 Apr 2020
Epidyolex is granted temporary subsidy
20 April 2020 - The TLV has decided that Epidyolex 100 mg /mL oral solution should be included in the ...
Posted by Michael Wonder on 20 Apr 2020
Additional analysis of Kymriah in the treatment of patients with diffuse large-cell B-cell lymphoma
17 April 2020 - TLV has conducted an additional analysis of the earlier evaluation of Kymriah (tisagenleclucel) in the treatment ...
Posted by Michael Wonder on 03 Apr 2020
The review shows that it is possible to lower the cost of medicines
3 April 2020 - There are opportunities to make savings on medicines. ...
Posted by Michael Wonder on 02 Apr 2020
Pharmacies may only dispense drugs for 90 days
1 April 2020 - As of today, April 1, pharmacies cannot deliver a larger amount of drug than the amount ...